| Tretinoin | Approved Investigational Nutraceutical | ABAT | 18 |
upregulated | Tretinoin results in increased expression of ABAT mRNA | 16p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCA1 | 19 |
upregulated | Tretinoin results in increased expression of ABCA1 mRNA | 9q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCA12 | 26154 |
downregulated | Tretinoin results in decreased expression of ABCA12 mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCA5 | 23461 |
upregulated | Tretinoin results in increased expression of ABCA5 mRNA | 17q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCA7 | 10347 |
upregulated | Tretinoin results in increased expression of ABCA7 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCB1 | 5243 |
upregulated | Tretinoin results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCB10 | 23456 |
downregulated | Tretinoin results in decreased expression of ABCB10 mRNA | 1q42.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCB4 | 5244 |
upregulated | Tretinoin results in increased expression of ABCB4 mRNA | 7q21.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCC3 | 8714 |
upregulated | Tretinoin results in increased expression of ABCC3 mRNA | 17q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCC4 | 10257 |
downregulated | Tretinoin results in decreased expression of ABCC4 mRNA | 13q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCC4 | 10257 |
upregulated | Tretinoin results in increased expression of ABCC4 mRNA | 13q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCC6 | 368 |
upregulated | Tretinoin results in increased expression of ABCC6 mRNA | 16p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCD3 | 5825 |
upregulated | Tretinoin results in increased expression of ABCD3 mRNA | 1p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCE1 | 6059 |
downregulated | Tretinoin results in decreased expression of ABCE1 mRNA | 4q31.21 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCG1 | 9619 |
upregulated | Tretinoin results in increased expression of ABCG1 mRNA | 21q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ABCG2 | 9429 |
upregulated | Tretinoin results in increased expression of ABCG2 mRNA | 4q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ABHD11 | 83451 |
upregulated | Tretinoin results in increased expression of ABHD11 mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | ABI2 | 10152 |
upregulated | Tretinoin results in increased expression of ABI2 mRNA | 2q33.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ACACA | 31 |
downregulated | Tretinoin results in decreased expression of ACACA mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | ACACB | 32 |
downregulated | Tretinoin results in decreased expression of ACACB mRNA | 12q24.11 | |
| Tretinoin | Approved Investigational Nutraceutical | ACADM | 34 |
upregulated | Tretinoin results in increased expression of ACADM mRNA | 1p31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ACADVL | 37 |
upregulated | Tretinoin results in increased expression of ACADVL mRNA | 17p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ACAN | 176 |
downregulated | Tretinoin results in decreased expression of ACAN mRNA | 15q26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ACAT2 | 39 |
downregulated | Tretinoin results in decreased expression of ACAT2 mRNA | 6q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ACKR3 | 57007 |
upregulated | Tretinoin results in increased expression of ACKR3 mRNA | 2q37.3 | |